Search Results - "AlJoudeh, Amer"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)

    Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio) by Salehi, Mahan, Iqbal, Mubashar, Dube, Asha, AlJoudeh, Amer, Edenborough, Frank

    Published in Respiratory medicine case reports (01-01-2021)
    “…The introduction of Cystic Fibrosis Trans Regulatory modulator (CFTRm) drugs has seen a transformation in Cystic Fibrosis (CF) treatment. This has led to a…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Mesalazine-induced lung fibrosis

    Mesalazine-induced lung fibrosis by Alskaf, Ebraheem, Aljoudeh, Amer, Edenborough, Frank

    Published in BMJ case reports (09-04-2013)
    “…The medical management of a patient with Crohn's disease should take into account the activity, site and behaviour of disease, and should be discussed with the…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)

    Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio) by Salehi, Mahan, Iqbal, Mubashar, Dube, Asha, AlJoudeh, Amer, Edenborough, Frank

    Published in Respiratory medicine case reports (01-01-2021)
    Get full text
    Report
    Save to List
    Saved in:
  4. 4
    Mesalazine-induced lung fibrosis

    Mesalazine-induced lung fibrosis by Alskaf, Ebraheem, Aljoudeh, Amer, Edenborough, Frank

    Published in BMJ Case Reports (09-04-2013)
    “…The medical management of a patient with Crohn's disease should take into account the activity, site and behaviour of disease, and should be discussed with the…”
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: